Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • ggrter ggrter Jan 10, 2014 9:39 AM Flag

    insider sold this week, it did not take very long!

    Gorman Kevin Charles who is President and CEO at Neurocrine Biosciences sold 108,000 shares at $16.76 on Jan. 8, 2014. Following this transaction, the President and CEO owned 177,202 shares meaning that the stake was reduced by 37.87% with the 108,000-share transaction.

    OBrien Christopher Flint who is Chief Medical Officer at Neurocrine Biosciences sold 5,000 shares at $17.50 on Jan. 8, 2014. Following this transaction, the Chief Medical Officer owned 94,794 shares meaning that the stake was reduced by 5.01% with the 5,000-share transaction.

    Coughlin Timothy P who is Chief Financial Officer at Neurocrine Biosciences sold 70,000 shares at $16.75 on Jan. 8, 2014. Following this transaction, the Chief Financial Officer owned 96,124 shares meaning that the stake was reduced by 42.14% with the 70,000-share transaction.

    Bozigian Haig P. who is Chief Development Officer at Neurocrine Biosciences sold 25,000 shares at $17.50 on Jan. 8, 2014. Following this transaction, the Chief Development Officer owned 76,954 shares meaning that the stake was reduced by 24.52% with the 25,000-share transaction.

    Grigoriadis Dimitri E. who is Chief Research Officer at Neurocrine Biosciences sold 25,000 shares at $17.50 on Jan. 8, 2014. Following this transaction, the Chief Research Officer owned 75,433 shares meaning that the stake was reduced by 24.89% with the 25,000-share transaction.

 
NBIX
48.96+0.87(+1.81%)10:33 AMEDT